I think that currently, there are a lot of people that

New Post Public Reply Private Reply Replies (1) Message Board
picon
I think that currently, there are a lot of people that are trying to figure out when to start trading CNRX , when it comes to short term and long term timelines.
The link below indicates , with some accuracy considering how slow government acts on anything , that CNRX if definitely a longer term play......In my view.....of course.
That said, I think that what should NOT be forgotten, is that CNRX is far, far, away from being anywhere close to a one trick pony, in which legalization of MJ would be the true priority in their business model. A large part....well sure, but the overall vision of our CEO surpasses simply legalization in Canada, as we all know.

The key to everything is based on really 2 components.
1st: is the OMB ruling which we should get in January or early February of 16.
The 2nd : Is the MUCH anticipated ruling from the Judicial Review from the Court's in Canada concerning the actions of Health Canada.
I am, as I am pretty sure most of us are, very confident that we will be granted a license as a result of the decision of the review.

At this point....I am not really concerned with the legal issues concerning being made financially whole. The reasons for that have all to do with the results of the primary 2 issues first mentioned.
If we win, and I am confident we will on the first 2.....well, the third issue is no longer an issue at all. It just becomes then, a matter of how much remuneration is allotted, and in what form.

All of the above said , I can think of NO REASON , why , this new ticker , CNRX would not simply continue to keep rising over the next 2 - 5 years at a minimum. A lot of things will change concerning MJ over the next 5 years to say the least.
One of the most important....again, in my view, is the fact that once things settle out with legalization , we will see the Super Structure Health care, multinational Corporations , that have the money , and research and development facilities already integrated into their respective business model's begin a consolidation through acquisition and mergers , like a starving wolf that just found a heard of sheep. Money will not be the issue. Who is first , and biggest will definitely be the issue. I think , CNRX will be perfectly situated to be involved in all of the things that the MEGA companies will be after, in light of the fact that CNRX will have already done the work , and now all that is needed is scale. The Mega Companies can provide that.

So, I think when we speak about when , how long , and benefit of making a sound decision , that it would be advantageous to consider all of the above. Solid long term hold for me. This is money I am just going to forget that I have invested for at least 5 years and most likely closer to 10 . Just depends on what happens way down the road. All JMO.....of course. GLTA

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
In times when you feel low self esteem, disappointment and perhaps even depression.......keep in mind that it may simply be the result of the fact that you are surrounded by ass holes. GLTA
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading

Top 5 Most Recently Viewed Articles

NVIDIA and Synopsys Forge Alliance to Transform Engineering

Updated Category News Views 137

Strategic Collaboration Between NVIDIA and Synopsys In an exciting development for the engineering and design industries, NVIDIA and Synopsys have joined forces in a strategic partnership that promises to revolutionize how these sectors operate. This collaboration aims to leverage NVIDIA's powerful computational capabilities alongside Synopsys' sophisticated engineering...

Continue Reading
EHang's Groundbreaking Pilotless Flight Marks a Historic Event

Updated Category News Views 110

EHang's Historic Pilotless Flight in Africa EHang Holdings Limited (Nasdaq: EH), a frontrunner in Urban Air Mobility (UAM), has made headlines by achieving a remarkable milestone: the first pilotless human-carrying flight of its EH216-S eVTOL aircraft in Africa. This significant event unfolded at the 9th Aviation Africa Summit in Kigali, marking a historic moment for the...

Continue Reading
Bang & Olufsen's Share Buyback: Strategic Moves for Growth

Updated Category News Views 112

Understanding Bang & Olufsen's Share Buyback Program Bang & Olufsen A/S has embarked on a significant initiative aimed at bolstering its long-term growth through its recent share buyback program. This strategic move is designed to hedge the company’s share-based long-term incentive programmes, showcasing their commitment to enhancing shareholder value. This article...

Continue Reading
Johnson & Johnson's Q2 Expectations and Analyst Ratings Insights

Updated Category News Views 275

Upcoming Earnings Announcement for Johnson & Johnson Johnson & Johnson (NYSE: JNJ) is preparing to disclose its earnings results for the upcoming second quarter. Analysts are closely watching the anticipated report, which is expected to provide valuable insights into the company's financial health. Expected Financial Performance Analyst forecasts suggest that Johnson &...

Continue Reading
Safe House Project Expands Impact with ATI Acquisition

Updated Category News Views 307

Safe House Project Expands Impact with ATI Acquisition This Giving Tuesday, the Safe House Project (SHP) shared exciting news about its acquisition of Anti-Trafficking International (ATI), an organization that has been pivotal in the fight against human trafficking. By incorporating ATI's respected practices and its renowned Just Ask Prevention Curriculum, SHP aims to...

Continue Reading